Potassium canrenoate

Potassium canrenoate
Systematic (IUPAC) name
potassium 3-[(8R,9S,10R,13S,14S,17R)-
17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,
11,12,14,15,16-octahydro-1H-cyclopenta[a]
phenanthren-17-yl]propanoate
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Intravenous
Pharmacokinetic data
Metabolism Hepatic
Excretion Renal and fecal
Identifiers
CAS Number 2181-04-6 N
ATC code C03DA02
PubChem CID 656614
DrugBank DB09015 N
ChemSpider 570975 YesY
UNII M671F9NLEA N
ChEMBL CHEMBL1371200 N
Synonyms SC-14266
Chemical data
Formula C22H29KO4
Molar mass 396.5616 g/mol
 NYesY (what is this?)  (verify)

Potassium canrenoate (INN, JAN) or canrenoate potassium (USAN) (brand names Venactone, Soldactone), the potassium salt of canrenoic acid, is an aldosterone antagonist of the spirolactone group.[1] Like spironolactone, it is a prodrug, which is metabolized to canrenone in the body. Potassium canrenoate is not licensed in the UK, but may sometimes be prescribed off-licence to treat oedema. It is given intravenously.

See also

References

  1. R.A. Hill; H.L.J. Makin; D.N. Kirk; G.M. Murphy (23 May 1991). Dictionary of Steroids. CRC Press. pp. 656–. ISBN 978-0-412-27060-4.



This article is issued from Wikipedia - version of the Friday, January 01, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.